Actively Recruiting
Neglect Treatment by Prism Adaptation in the Acute Phase
Led by University of Geneva, Switzerland · Updated on 2024-06-27
32
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This project aims at unveiling the beneficial effects of prism adaptation as early rehabilitation technique to treat unilateral spatial neglect in the acute phase after a brain damage. This syndrome, frequent and very invalidating for daily life activities after a brain damage, is a cognitive disorder of lack of attention towards a part of the space. Patients at a first event brain injury hospitalized into the Neurology and Neurosurgery Departments and affected by spatial neglect will undergo to a protocol of five consecutive rehabilitation treatments, being assigned to the experimental (prisms) or control groups (neutral prisms). The effectiveness of the treatment will be assessed with cognitive, functional and motor-related measures, as well as a follow up 3 months later. These results can have a strong impact on the long-term functional outcome of these patients.
CONDITIONS
Official Title
Neglect Treatment by Prism Adaptation in the Acute Phase
Who Can Participate
Eligibility Criteria
You may qualify if you...
- First neurological event affecting the right or left hemisphere (stroke, brain tumor post-surgery)
- Structural brain lesion images available (MRI or CT scans)
- Normal or corrected normal vision
- Presence of unilateral spatial neglect confirmed by standard neuropsychological evaluation
You will not qualify if you...
- Previous neurological disorder or current/previous psychiatric disease
- Known or suspected prior general cognitive deficits
- Difficulty understanding tasks that prevents completion
- Unable to sustain a research session of at least 30 minutes due to attentional issues
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital of Geneva
Geneva, Canton of Geneva, Switzerland, 1200
Actively Recruiting
Research Team
R
Roberta Ronchi, PhD
CONTACT
J
Jennifer Martin, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here